Want to know the venture capital funds that invest in biotech and healthcare in Korea?
According to the Startup Genome Report 2020, Seoul was considered one of the top 20 startup ecosystems in the world. Korea already has 15 unicorns. Its startup ecosystem is active and well-designed, attracting the attention of investors, accelerators and incubators from around the world. Last year, the committed capital of Korean VCs reached $ 3.9 billion, double what it was four years ago, when it stood at around $ 1.9 billion.
Do not miss this virtual session where, with the help of the Foreign Trade and Investment Office of Catalonia in Seoul, we will connect with investors who will share with us what criteria they follow when selecting the projects in which they invest in. We will be accompanied by KB Investment, Shinhan Venture Investment, Mirae Asset Venture Investment and AJU IB Investment.
In addition, MINT Venture Partners, a global venture builder specialized in biotech and healthcare, will show us a presentation on ecosystem trends in Korea. Afterwards, a closed pitch session of Catalan startups will be held in front of investors.
- 09.00 am – Welcome
- 09.05 am – Trends in the South Korean ecosystem
Dr. Jae Hoon Song, founder & CEO at MINT Venture Partners
- 9.25 am – Introduction to investors KB Investment, Shinhan Venture Investment, Mirae Asset Venture Investment, and AJU IB Investment
- 09.45 am – Question Time
- 10.00 am – Closing
The session will be done in Catalan, Spanish and English.
The investing ecosystem in life sciences and health in South Korea